Skip to main content

Table 1 Correlation between MACC1-AS1, MACC1 and clinicopathological parameters

From: The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1

n (%) MACC1-AS1 MACC1
Low and negative (n) High (n) P Low and Negative (n) High (n) P
Age (years)    0.752    0.803
 ≥55 72(58.5%) 43 29   45 27  
 <55 51(41.5%) 29 22   33 18  
Sex     0.351    
 Male 76(61.8%) 42 34   45 31 0.22
 Female 47(38.2%) 30 17   33 14  
TNM stage    0.022*    0.002**
 I 17(13.8%) 15 2   14 3  
 II 25(20.3%) 14 11   19 6  
 III 43(35.0%) 25 18   28 15  
 IV 38(30.9%) 18 20   17 21  
Tumor invasion    0.024*    0.135
 T1 12(9.8%) 10 2   9 3  
 T2 14(11.4%) 10 4   11 3  
 T3 50(40.7%) 29 21   31 19  
 T4 47(38.2%) 23 24   27 20  
Lymph node metastasis    0.004**    0.034*
 N0 29(23.6%) 22 7   13 13  
 N1 34(27.7%) 20 14   20 14  
 N2 34(27.7%) 22 12   23 11  
 N3 26(21.1%) 8 18   22 7  
Distant metastasis    0.065    0.055
 M0 101(82.1%) 63 38   68 33  
 M1 22(17.9%) 9 13   10 12  
Tumor differentiation    0.963    0.923
 Well 6(4.9%) 5 1   5 1  
 Moderate 20(16.3%) 10 10   11 9  
 Poor 97(78.9%) 57 40   62 35  
Mortality    0.213    0.138
 Survive 13(34.2%) 8 5   8 5  
 die 25(65.8%) 10 15   9 16  
Recurrence    0.012*    0.114
 No 40(47.1%) 31 9   32 8  
 Yes 45(52.9%) 23 22   29 16  
  1. *P<0.05; **P<0.01